Systematic review of interventions in the management of overweight and obese children which include a dietary

Clare E Collins1, Janet M Warren, Melinda Neve

  • 1The Australian Centre for Evidence Based Nutrition and Dietetics: a collaborating centre of the Joanna Briggs Institute, School of Health Sciences and Discipline of Clinical Pharmacology, Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia.

Insights

Childhood obesity is a growing concern, and dietary interventions show short-term weight loss. However, more high-quality research is needed to determine long-term effectiveness and optimal approaches for pediatric overweight and obesity management.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Nutrition
  • Evidence-Based Medicine

Background:

  • Childhood overweight and obesity prevalence is increasing globally, necessitating effective public health interventions.
  • Diet plays a crucial role in managing pediatric obesity, yet evidence-based guidelines are limited.
  • Effective management of pediatric obesity is vital to reduce associated morbidity and mortality.

Purpose of the Study:

  • To identify and synthesize the best available evidence on optimal dietary interventions for overweight and obese children and adolescents.
  • To inform clinical practice with evidence-based recommendations for pediatric obesity management.

Main Methods:

  • A comprehensive literature search was conducted across multiple electronic databases (CINAHL, MEDLINE, EMBASE, etc.) and grey literature from 1975 to 2003.
  • Studies were included if they evaluated dietary interventions for overweight/obese participants under 18 years.
  • Included studies were critically appraised for methodological quality, with data extracted and discrepancies arbitrated.

Main Results:

  • 116 articles met the inclusion criteria, comprising 37 randomized controlled trials and 67 non-randomized trials.
  • Dietary interventions generally led to significant short-term weight loss, but study heterogeneity and poor design were common.
  • Many studies lacked adequate follow-up, detailed dietary descriptions, and reporting of diet-specific outcomes, hindering reproducibility.

Conclusions:

  • There is an urgent need for high-quality research into optimal dietary strategies for pediatric overweight and obesity.
  • Future studies must include adequate follow-up to assess long-term weight loss sustainability.
  • Detailed reporting of dietary prescriptions, adherence, and diet-specific outcomes is essential for evidence-based practice.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...